✦ LIBER ✦

729 10-YEAR SURVIVAL ANALYSIS FOR PATIENTS WITH RENAL CELL CARCINOMA TREATED WITH AN AUTOLOGOUS TUMOUR CELL LYSATE VACCINE IN AN ADJUVANT SETTING

✍ Scribed by S. Brookman-May; M. Burger; W.F. Wieland; Ch. Gilfrich; M. May

Book ID: 119623068
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 175 KB
Volume: 10
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(11)60717-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ten-year survival analysis for renal car

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting

✍ Matthias May; Sabine Brookman-May; Bernd Hoschke; Christian Gilfrich; Friederike 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 369 KB

Re: Ten-Year Survival Analysis for Renal

Re: Ten-Year Survival Analysis for Renal Carcinoma Patients Treated With an Autologous Tumour Lysate Vaccine in an Adjuvant Setting

✍ Jens Rassweiler 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

AN ADJUVANT VACCINATION WITH RENIALE® PR

AN ADJUVANT VACCINATION WITH RENIALE® PROLONGS SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING RADICAL NEPHRECTOMY: SECONDARY ANALYSIS OF A MULTICENTRE PHASE-III TRIAL

✍ Doehn, C.; Richter, A.; Theodor, R.A.; Lehmacher, W.; Jocham, D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Gender differences in clinicopathologica

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database

✍ Matthias May, Atiqullah Aziz, Richard Zigeuner… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Improvement in Overall Survival of Patie

Improvement in Overall Survival of Patients with Advanced Renal Cell Carcinoma: Prognostic Factor Trend Analysis from an International Data Set of Clinical Trials

✍ Patil, Sujata; Manola, Judith; Elson, Paul; Negrier, Sylvie; Escudier, Bernard; 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 735 KB

Validation of the MSKCC and Heng Risk Cr

Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib

✍ Whi-An Kwon MD,In-Chang Cho MD,Ami Yu PhD,Byung-Ho Nam MD… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 377 KB